Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Ms Charise Gleason on Optimizing Patient Care

54:33
 
Share
 

Manage episode 504846945 series 1464173
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Featuring an interview with Ms Charise Gleason, including the following topics:

  • Progress and change in the management of multiple myeloma (MM) (0:00)
  • Patient- and disease-specific factors guiding therapeutic decision-making for newly diagnosed MM (5:11)
  • Role of anti-CD38 antibodies in the management of MM (12:14)
  • Emerging treatment options for smoldering myeloma (23:08)
  • Optimizing long-term outcomes for patients with MM (25:38)
  • Tailoring therapy for older adults and patients with preexisting comorbidities (29:59)
  • Case: A woman in her early 80s with newly diagnosed transplant-ineligible MM who experienced a complete response with first-line daratumumab/lenalidomide and low-dose dexamethasone (34:34)
  • Case: A man in his early 60s with progressive back pain from standard-risk MM who experienced a complete response with daratumumab with lenalidomide/bortezomib/dexamethasone (42:05)
  • Building therapeutic relationships and integrating holistic care in oncology practice (47:13)

NCPD information and select publications

  continue reading

960 episodes

Artwork
iconShare
 
Manage episode 504846945 series 1464173
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Featuring an interview with Ms Charise Gleason, including the following topics:

  • Progress and change in the management of multiple myeloma (MM) (0:00)
  • Patient- and disease-specific factors guiding therapeutic decision-making for newly diagnosed MM (5:11)
  • Role of anti-CD38 antibodies in the management of MM (12:14)
  • Emerging treatment options for smoldering myeloma (23:08)
  • Optimizing long-term outcomes for patients with MM (25:38)
  • Tailoring therapy for older adults and patients with preexisting comorbidities (29:59)
  • Case: A woman in her early 80s with newly diagnosed transplant-ineligible MM who experienced a complete response with first-line daratumumab/lenalidomide and low-dose dexamethasone (34:34)
  • Case: A man in his early 60s with progressive back pain from standard-risk MM who experienced a complete response with daratumumab with lenalidomide/bortezomib/dexamethasone (42:05)
  • Building therapeutic relationships and integrating holistic care in oncology practice (47:13)

NCPD information and select publications

  continue reading

960 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play